| efavirenz 600 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet efavirenz | 5,067 | 100%
| T4 | 0% | 1,779 |
| efavirenz 400 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet efavirenz | 5,067 | 100%
| T4 | 0% | 1,779 |
| efavirenz 600 MG Oral Tablet efavirenz | 5,067 | 100%
| T3 | 0% | 1,779 |
| tranylcypromine 10 MG Oral Tablet tranylcypromine | 5,067 | 100%
| T3 | 0% | 1,773 |
| 1.5 ML aripiprazole 200 MG/ML Prefilled Syringe [Abilify] aripiprazole | 5,067 | 100%
| T4 | 3.6% | 1,736 |
| 2 ML aripiprazole 200 MG/ML Prefilled Syringe [Abilify] aripiprazole | 5,067 | 100%
| T4 | 3.6% | 1,736 |
| bosutinib 100 MG Oral Tablet [Bosulif] bosutinib | 5,067 | 100%
| T4 | 99.4% | 1,732 |
| bosutinib 500 MG Oral Tablet [Bosulif] bosutinib | 5,067 | 100%
| T4 | 99.4% | 1,732 |
| bosutinib 400 MG Oral Tablet [Bosulif] bosutinib | 5,067 | 100%
| T4 | 99.4% | 1,732 |
| bosutinib 50 MG Oral Capsule [Bosulif] bosutinib | 5,067 | 100%
| T4 | 99.4% | 1,732 |
| vismodegib 150 MG Oral Capsule [Erivedge] vismodegib | 5,067 | 100%
| T4 | 99.4% | 1,719 |
| streptomycin 1000 MG Injection streptomycin | 5,067 | 100%
| T4 | 9.1% | 1,682 |
| maraviroc 150 MG Oral Tablet maraviroc | 5,067 | 100%
| T4 | 0% | 1,674 |
| maraviroc 300 MG Oral Tablet maraviroc | 5,067 | 100%
| T4 | 0% | 1,674 |
| maraviroc 20 MG/ML Oral Solution [Selzentry] maraviroc | 5,067 | 100%
| T4 | 0% | 1,674 |
| {28 (alpelisib 200 MG Oral Tablet [Piqray]) } Pack [Piqray 200 MG Daily Dose] alpelisib | 5,067 | 100%
| T4 | 99.4% | 1,673 |
| {56 (alpelisib 150 MG Oral Tablet [Piqray]) } Pack [Piqray 300 MG Daily Dose] alpelisib | 5,067 | 100%
| T4 | 99.4% | 1,673 |
| {28 (alpelisib 200 MG Oral Tablet [Piqray]) / 28 (alpelisib 50 MG Oral Tablet [Piqray]) } Pack [Piqray 250 MG Daily Dose] alpelisib | 5,067 | 100%
| T4 | 99.4% | 1,673 |
| colistin 75 MG/ML Injectable Solution colistin | 5,067 | 100%
| T3 | 13.9% | 1,652 |
| elacestrant 86 MG Oral Tablet [Orserdu] elacestrant | 5,067 | 100%
| T4 | 99.4% | 1,640 |
| elacestrant 345 MG Oral Tablet [Orserdu] elacestrant | 5,067 | 100%
| T4 | 99.4% | 1,640 |
| pazopanib 200 MG Oral Tablet pazopanib | 5,067 | 100%
| T4 | 99.4% | 1,555 |
| 0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection [ActHIB] Haemophilus influenzae type b strain | 5,067 | 100%
| T2 | 0% | 1,548 |
| chloroquine phosphate 250 MG Oral Tablet chloroquine phosphate | 5,067 | 100%
| T3 | 0% | 1,536 |
| chloroquine phosphate 500 MG Oral Tablet chloroquine phosphate | 5,067 | 100%
| T3 | 0% | 1,536 |
| sotorasib 120 MG Oral Tablet [Lumakras] sotorasib | 5,067 | 100%
| T4 | 99.4% | 1,527 |
| sotorasib 320 MG Oral Tablet [Lumakras] sotorasib | 5,067 | 100%
| T4 | 99.4% | 1,527 |
| sotorasib 240 MG Oral Tablet [Lumakras] sotorasib | 5,067 | 100%
| T4 | 99.4% | 1,527 |
| albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution albuterol | 5,067 | 100%
| T2 | 99.7% | 1,487 |
| albuterol 0.83 MG/ML Inhalation Solution albuterol | 5,067 | 100%
| T2 | 99.7% | 1,487 |
| alectinib 150 MG Oral Capsule [Alecensa] alectinib | 5,067 | 100%
| T4 | 99.4% | 1,459 |
| aztreonam 75 MG/ML Inhalation Solution [Cayston] aztreonam | 5,067 | 100%
| T4 | 94.5% | 1,454 |
| aztreonam 1000 MG Injection aztreonam | 5,067 | 100%
| T3 | 8.5% | 1,454 |
| protriptyline hydrochloride 5 MG Oral Tablet protriptyline hydrochloride | 5,067 | 100%
| T3 | 5.8% | 1,381 |
| protriptyline hydrochloride 10 MG Oral Tablet protriptyline hydrochloride | 5,067 | 100%
| T3 | 5.8% | 1,381 |
| sunitinib 12.5 MG Oral Capsule sunitinib | 5,067 | 100%
| T4 | 99.1% | 1,343 |
| sunitinib 25 MG Oral Capsule sunitinib | 5,067 | 100%
| T4 | 99.1% | 1,343 |
| sunitinib 37.5 MG Oral Capsule sunitinib | 5,067 | 100%
| T4 | 99.1% | 1,343 |
| sunitinib 50 MG Oral Capsule sunitinib | 5,067 | 100%
| T4 | 99.1% | 1,343 |
| encorafenib 75 MG Oral Capsule [Braftovi] encorafenib | 5,067 | 100%
| T4 | 99.4% | 1,328 |
| rifapentine 150 MG Oral Tablet [Priftin] rifapentine | 5,067 | 100%
| T3 | 0% | 1,302 |
| nefazodone hydrochloride 100 MG Oral Tablet nefazodone hydrochloride | 5,067 | 100%
| T3 | 0% | 1,249 |
| nefazodone hydrochloride 200 MG Oral Tablet nefazodone hydrochloride | 5,067 | 100%
| T3 | 0% | 1,249 |
| nefazodone hydrochloride 250 MG Oral Tablet nefazodone hydrochloride | 5,067 | 100%
| T3 | 0% | 1,249 |
| nefazodone hydrochloride 150 MG Oral Tablet nefazodone hydrochloride | 5,067 | 100%
| T3 | 0% | 1,249 |
| nefazodone hydrochloride 50 MG Oral Tablet nefazodone hydrochloride | 5,067 | 100%
| T3 | 0% | 1,249 |
| 12 HR fostemsavir 600 MG Extended Release Oral Tablet [Rukobia] fostemsavir | 5,067 | 100%
| T4 | 0% | 1,227 |
| pyrazinamide 500 MG Oral Tablet pyrazinamide | 5,067 | 100%
| T3 | 0% | 1,225 |
| ivosidenib 250 MG Oral Tablet [Tibsovo] ivosidenib | 5,067 | 100%
| T4 | 99.4% | 1,183 |
| quinine sulfate 324 MG Oral Capsule quinine sulfate | 5,067 | 100%
| T3 | 84.8% | 1,138 |
| {24 (selinexor 20 MG Oral Tablet [Xpovio]) } Pack [Xpovio 60 MG Twice Weekly (120 MG total weekly dose) Carton] selinexor | 5,067 | 100%
| T4 | 99.4% | 1,117 |
| {32 (selinexor 20 MG Oral Tablet [Xpovio]) } Pack [Xpovio 80 MG Twice Weekly (160 MG total weekly dose) Carton] selinexor | 5,067 | 100%
| T4 | 99.4% | 1,117 |
| {8 (selinexor 40 MG Oral Tablet [Xpovio]) } Pack [Xpovio 80 MG Once Weekly Carton-40 MG Tablets] selinexor | 5,067 | 100%
| T4 | 99.4% | 1,117 |
| {8 (selinexor 40 MG Oral Tablet [Xpovio]) } Pack [Xpovio 40 MG Twice Weekly (80 MG total weekly dose- 40 MG Tablets) Carton] selinexor | 5,067 | 100%
| T4 | 99.4% | 1,117 |
| {4 (selinexor 40 MG Oral Tablet [Xpovio]) } Pack [Xpovio 40 MG Once Weekly Carton-40 MG Tablet] selinexor | 5,067 | 100%
| T4 | 99.4% | 1,117 |
| {8 (selinexor 50 MG Oral Tablet [Xpovio]) } Pack [Xpovio 100 MG Once Weekly Carton-50 MG Tablets] selinexor | 5,067 | 100%
| T4 | 99.4% | 1,117 |
| {4 (selinexor 60 MG Oral Tablet [Xpovio]) } Pack [Xpovio 60 MG Once Weekly Carton-60 MG Tablet] selinexor | 5,067 | 100%
| T4 | 99.4% | 1,117 |
| {16 (selinexor 10 MG Oral Tablet [Xpovio]) } Pack [Xpovio 40 MG Once Weekly Carton-10 MG Tablet] selinexor | 5,067 | 100%
| T4 | 98.8% | 1,117 |
| mifepristone 300 MG Oral Tablet mifepristone | 5,067 | 100%
| T4 | 99.7% | 1,059 |
| emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet emtricitabine | 5,067 | 100%
| T3 | 0% | 997 |
| emtricitabine 200 MG / rilpivirine 25 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet emtricitabine | 5,067 | 100%
| T4 | 0% | 997 |
| emtricitabine 10 MG/ML Oral Solution [Emtriva] emtricitabine | 5,067 | 100%
| T3 | 0% | 997 |
| emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet [Descovy] emtricitabine | 5,067 | 100%
| T4 | 0% | 997 |
| emtricitabine 120 MG / tenofovir alafenamide 15 MG Oral Tablet [Descovy] emtricitabine | 5,067 | 100%
| T4 | 0% | 997 |
| emtricitabine 200 MG / rilpivirine 25 MG / tenofovir alafenamide 25 MG Oral Tablet [Odefsey] emtricitabine | 5,067 | 100%
| T4 | 0% | 997 |
| emtricitabine 200 MG Oral Capsule emtricitabine | 5,067 | 100%
| T3 | 0% | 997 |
| emtricitabine 100 MG / tenofovir disoproxil fumarate 150 MG Oral Tablet emtricitabine | 5,067 | 100%
| T3 | 0% | 997 |
| emtricitabine 133 MG / tenofovir disoproxil fumarate 200 MG Oral Tablet emtricitabine | 5,067 | 100%
| T4 | 0% | 997 |
| emtricitabine 167 MG / tenofovir disoproxil fumarate 250 MG Oral Tablet emtricitabine | 5,067 | 100%
| T3 | 0% | 997 |
| capmatinib 150 MG Oral Tablet [Tabrecta] capmatinib | 5,067 | 100%
| T4 | 99.4% | 978 |
| capmatinib 200 MG Oral Tablet [Tabrecta] capmatinib | 5,067 | 100%
| T4 | 99.4% | 978 |
| nevirapine 200 MG Oral Tablet nevirapine | 5,067 | 100%
| T2 | 0% | 977 |
| nevirapine 10 MG/ML Oral Suspension nevirapine | 5,067 | 100%
| T3 | 0% | 977 |
| erlotinib 100 MG Oral Tablet erlotinib | 5,067 | 100%
| T4 | 97% | 956 |
| erlotinib 150 MG Oral Tablet erlotinib | 5,067 | 100%
| T4 | 97% | 956 |
| erlotinib 25 MG Oral Tablet erlotinib | 5,067 | 100%
| T4 | 97% | 956 |
| pacritinib 100 MG Oral Capsule [Vonjo] pacritinib | 5,067 | 100%
| T4 | 99.4% | 950 |
| tucatinib 50 MG Oral Tablet [Tukysa] tucatinib | 5,067 | 100%
| T4 | 99.4% | 936 |
| tucatinib 150 MG Oral Tablet [Tukysa] tucatinib | 5,067 | 100%
| T4 | 99.4% | 936 |
| gilteritinib 40 MG Oral Tablet [Xospata] gilteritinib | 5,067 | 100%
| T4 | 99.1% | 924 |
| tivozanib 0.89 MG Oral Capsule [Fotivda] tivozanib | 5,067 | 100%
| T4 | 99.1% | 923 |
| tivozanib 1.34 MG Oral Capsule [Fotivda] tivozanib | 5,067 | 100%
| T4 | 99.1% | 923 |
| sorafenib 200 MG Oral Tablet sorafenib | 5,067 | 100%
| T4 | 98.8% | 916 |
| bexarotene 75 MG Oral Capsule bexarotene | 5,067 | 100%
| T4 | 93.9% | 893 |
| bexarotene 0.01 MG/MG Topical Gel bexarotene | 5,067 | 100%
| T4 | 100% | 893 |
| 0.5 ML Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML Prefilled Syringe [Ixiaro] Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated | 5,067 | 100%
| T2 | 0% | 888 |
| ceftaroline fosamil 600 MG Injection [Teflaro] ceftaroline fosamil | 5,067 | 100%
| T4 | 9.1% | 887 |
| 24 HR selegiline 0.25 MG/HR Transdermal System [Emsam] selegiline | 5,067 | 100%
| T4 | 54.8% | 877 |
| 24 HR selegiline 0.375 MG/HR Transdermal System [Emsam] selegiline | 5,067 | 100%
| T4 | 54.8% | 877 |
| 24 HR selegiline 0.5 MG/HR Transdermal System [Emsam] selegiline | 5,067 | 100%
| T4 | 54.8% | 877 |
| selegiline hydrochloride 5 MG Oral Capsule selegiline hydrochloride | 5,067 | 100%
| T2 | 0% | 877 |
| binimetinib 15 MG Oral Tablet [Mektovi] binimetinib | 5,067 | 100%
| T4 | 99.4% | 875 |
| praziquantel 600 MG Oral Tablet praziquantel | 5,067 | 100%
| T3 | 0% | 855 |
| ponatinib 30 MG Oral Tablet [Iclusig] ponatinib | 5,067 | 100%
| T4 | 99.4% | 841 |
| ponatinib 45 MG Oral Tablet [Iclusig] ponatinib | 5,067 | 100%
| T4 | 99.4% | 841 |
| ponatinib 15 MG Oral Tablet [Iclusig] ponatinib | 5,067 | 100%
| T4 | 99.4% | 841 |
| ponatinib 10 MG Oral Tablet [Iclusig] ponatinib | 5,067 | 100%
| T4 | 99.4% | 841 |
| afatinib 30 MG Oral Tablet [Gilotrif] afatinib | 5,067 | 100%
| T4 | 99.4% | 816 |
| afatinib 40 MG Oral Tablet [Gilotrif] afatinib | 5,067 | 100%
| T4 | 99.4% | 816 |
| afatinib 20 MG Oral Tablet [Gilotrif] afatinib | 5,067 | 100%
| T4 | 99.4% | 816 |